John Wrangle

6.1k total citations
44 papers, 1.5k citations indexed

About

John Wrangle is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, John Wrangle has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 15 papers in Molecular Biology and 13 papers in Immunology. Recurrent topics in John Wrangle's work include Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (10 papers) and Epigenetics and DNA Methylation (10 papers). John Wrangle is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (10 papers) and Epigenetics and DNA Methylation (10 papers). John Wrangle collaborates with scholars based in United States, China and Singapore. John Wrangle's co-authors include Stephen B. Baylin, James G. Herman, Malcolm V. Brock, Steven A. Belinsky, Beverly Lee, Kristen Rodgers, Zihai Li, Craig M. Hooker, Noreli Franco and Charles M. Rudin and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

John Wrangle

44 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Wrangle United States 18 841 587 327 323 240 44 1.5k
Marc Oliva Spain 12 472 0.6× 519 0.9× 387 1.2× 271 0.8× 158 0.7× 41 1.2k
N. E. A. Crompton Switzerland 23 531 0.6× 421 0.7× 334 1.0× 409 1.3× 202 0.8× 53 1.5k
Ayman Oweida United States 19 336 0.4× 694 1.2× 129 0.4× 245 0.8× 423 1.8× 46 1.3k
Saied Mirshahidi United States 21 906 1.1× 300 0.5× 463 1.4× 157 0.5× 370 1.5× 66 1.5k
Gregory N. Gan United States 20 572 0.7× 807 1.4× 239 0.7× 954 3.0× 77 0.3× 60 1.8k
Pedro Pérez‐Segura Spain 18 407 0.5× 467 0.8× 294 0.9× 237 0.7× 136 0.6× 117 1.2k
Αreti Strati Greece 24 865 1.0× 1.0k 1.8× 1.1k 3.5× 426 1.3× 87 0.4× 48 1.9k
Michael Gonzalez United Kingdom 17 800 1.0× 436 0.7× 184 0.6× 116 0.4× 158 0.7× 32 1.3k
Robert Iannone United States 20 391 0.5× 980 1.7× 171 0.5× 312 1.0× 587 2.4× 43 2.1k
Rafael Malagoli Rocha Brazil 23 580 0.7× 482 0.8× 272 0.8× 369 1.1× 66 0.3× 71 1.5k

Countries citing papers authored by John Wrangle

Since Specialization
Citations

This map shows the geographic impact of John Wrangle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wrangle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wrangle more than expected).

Fields of papers citing papers by John Wrangle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Wrangle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wrangle. The network helps show where John Wrangle may publish in the future.

Co-authorship network of co-authors of John Wrangle

This figure shows the co-authorship network connecting the top 25 collaborators of John Wrangle. A scholar is included among the top collaborators of John Wrangle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Wrangle. John Wrangle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Hua, Hong-Fen Guo, Maegan L. Capitano, et al.. (2025). Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway. Nature Communications. 16(1). 6369–6369. 1 indexed citations
2.
Montealegre, Jane R., Haluk Damgacioglu, Brian Orr, et al.. (2025). County-Level Cervical Cancer Screening Coverage and Differences in Incidence and Mortality. JAMA Network Open. 8(8). e2526709–e2526709. 1 indexed citations
3.
McRae‐Clark, Aimee L., Kathleen T. Brady, Jacqueline F. McGinty, et al.. (2023). Novel Collaborations Across Training Programs to Support Mentoring in Sex Differences Research. Journal of Women s Health. 32(8). 865–868. 2 indexed citations
4.
Tsao, Anne S., Jeremy Cetnar, Boris Sepesi, et al.. (2021). OA13.01 S1619 A Trial of Neoadjuvant Cisplatin-Pemetrexed With Atezolizumab in Combination and Maintenance for Resectable Pleural Mesothelioma. Journal of Thoracic Oncology. 16(10). S870–S870. 7 indexed citations
5.
Wrangle, John, Vamsidhar Velcheti, Manish R. Patel, et al.. (2020). A37 N-803 Plus Nivolumab for Advanced or Metastatic Non-Small Cell Lung Cancer: Update on Phase II Experience of Combination PD1 Blockade with an IL-15 Superagonist. Journal of Thoracic Oncology. 15(2). S24–S25. 1 indexed citations
6.
Yoshida, Akihiro, Yiwen Bu, Shuo Qie, et al.. (2019). SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors. Science Advances. 5(9). eaax6352–eaax6352. 34 indexed citations
7.
Johnson, Christopher, Brian Riesenberg, Samantha Suriano, et al.. (2018). Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells. Cancer Research. 78(11). 3067–3074. 7 indexed citations
8.
Wrangle, John, Christopher Johnson, Shikhar Mehrotra, et al.. (2018). IL-2 and Beyond in Cancer Immunotherapy. Journal of Interferon & Cytokine Research. 38(2). 45–68. 97 indexed citations
9.
Bowers, Jacob S., Nathaniel S. O’Connell, Elizabeth Garrett‐Mayer, et al.. (2017). Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis. Cancer Immunology Immunotherapy. 66(6). 737–751. 6 indexed citations
10.
Hulbert, Alicia, Ignacio Jusué-Torres, Alejandro Stark, et al.. (2016). Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum. Clinical Cancer Research. 23(8). 1998–2005. 198 indexed citations
11.
Johnson, Christopher, John Wrangle, Shikhar Mehrotra, et al.. (2016). Harnessing the IL-7/IL-7Rαaxis to improve tumor immunotherapy. OncoImmunology. 5(5). e1122865–e1122865. 3 indexed citations
12.
Dimou, Anastasios, Carol A. Sherman, & John Wrangle. (2016). Imaging in Advanced Non–Small Cell Lung Cancer. Journal of Thoracic Imaging. 31(4). 238–242. 3 indexed citations
13.
Wrangle, John, Emi Ota Machida, Ludmila Danilova, et al.. (2014). Functional Identification of Cancer-Specific Methylation of CDO1 , HOXA9 , and TAC1 for the Diagnosis of Lung Cancer. Clinical Cancer Research. 20(7). 1856–1864. 65 indexed citations
14.
Vendetti, Frank P., Michael J. Topper, Peng Huang, et al.. (2014). Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer. Oncotarget. 6(1). 56–70. 24 indexed citations
15.
Keeley, Brian P., Alejandro Stark, Thomas R. Pisanic, et al.. (2013). Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events. Clinica Chimica Acta. 425. 169–175. 41 indexed citations
16.
Hooker, Craig M., Robert A. Meguid, Alicia Hulbert, et al.. (2012). Human Immunodeficiency Virus Infection as a Prognostic Factor in Surgical Patients With Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery. 93(2). 405–412. 25 indexed citations
17.
Shamay, Meir, Nicholas J. Hand, M. Victor Lemas, et al.. (2012). CpG Methylation as a Tool to Characterize Cell-Free Kaposi Sarcoma Herpesvirus DNA. The Journal of Infectious Diseases. 205(7). 1095–1099. 14 indexed citations
18.
Juergens, Rosalyn A., John Wrangle, Frank P. Vendetti, et al.. (2011). Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer. Cancer Discovery. 1(7). 598–607. 498 indexed citations
19.
Wrangle, John & Fadlo R. Khuri. (2007). Chemoprevention of squamous cell carcinoma of the head and neck. Current Opinion in Oncology. 19(3). 180–187. 18 indexed citations
20.
D’Angelo, Gerard, et al.. (1999). Mammal-specific, ERK-dependent, Caldesmon Phosphorylation in Smooth Muscle. Journal of Biological Chemistry. 274(42). 30115–30121. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Oliva Breakdown of academic impact, for papers by N. E. A. Crompton Breakdown of academic impact, for papers by Ayman Oweida Breakdown of academic impact, for papers by Saied Mirshahidi Breakdown of academic impact, for papers by Gregory N. Gan Breakdown of academic impact, for papers by Pedro Pérez‐Segura Breakdown of academic impact, for papers by Αreti Strati Breakdown of academic impact, for papers by Michael Gonzalez Breakdown of academic impact, for papers by Robert Iannone Breakdown of academic impact, for papers by Rafael Malagoli Rocha
Rankless by CCL
2026